Transcendent Capital Group LLC Pfizer Inc Transaction History

Transcendent Capital Group LLC

  • $178 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$27.7 - $31.39 $1,163 - $1,318
-42 Reduced 0.8%
5,176 $150 Million
Q2 2024

Jul 24, 2024
SELL
$25.26 - $29.6 $1,161 - $1,361
-46 Reduced 0.87%
5,218 $146 Million
Q4 2023

Mar 01, 2024
BUY
$26.13 - $33.94 $137,548 - $178,660
5,264 New
5,264 $152 Million

Others Institutions Holding PFE

# of Institutions
3,371
Shares Held
3.61B
Call Options Held
102M
Put Options Held
130M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $136B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email